Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. (2019)

First Author: Miao L
Attributed to:  E-TERM, Engineering Tissue Engineering and Regenerative Medicine funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41587-019-0247-3

PubMed Identifier: 31570898

Publication URI: http://europepmc.org/abstract/MED/31570898

Type: Journal Article/Review

Volume: 37

Parent Publication: Nature biotechnology

Issue: 10

ISSN: 1087-0156